Literature DB >> 2475572

Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation.

N Khalil1, O Bereznay, M Sporn, A H Greenberg.   

Abstract

A rat model of bleomycin-induced pulmonary inflammation and fibrosis was used to examine the relationship between collagen synthesis and transforming growth factor beta (TGF-beta) production, and cellular distribution. Total lung TGF-beta was elevated within 2 h of intratracheal bleomycin administration and peaked 7 d later at levels 30-fold higher than controls. This was followed by a gradual decline with lower but persistent levels of production in the late phase of the response between 21 and 28 d later. The peak TGF-beta levels preceded the maximum collagen and noncollagen protein synthesis measured by [3H]proline incorporation into lung fibroblast explants of bleomycin-treated rats. The pattern of immunohistochemical staining localized TGF-beta initially in the cytoplasm of bronchiolar epithelium cells and subepithelial extracellular matrix. The peak of lung TGF-beta levels at 7 d coincided with intense TGF-beta staining of macrophages dispersed in the alveolar interstitium and in organized clusters. Later in the course of the response. TGF-beta was primarily associated with extracellular matrix in regions of increased cellularity and tissue repair, and coincided with the maximum fibroblast collagen synthesis. This temporal and spatial relationship between collagen production and TGF-beta production by macrophages suggests an important if not primary role for TGF-beta in the pathogenesis of the pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475572      PMCID: PMC2189427          DOI: 10.1084/jem.170.3.727

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix.

Authors:  R A Ignotz; J Massagué
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

2.  Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters.

Authors:  D B Chandler; D M Hyde; S N Giri
Journal:  Am J Pathol       Date:  1983-08       Impact factor: 4.307

Review 3.  Interstitial lung disease: current concepts of pathogenesis, staging and therapy.

Authors:  R G Crystal; J E Gadek; V J Ferrans; J D Fulmer; B R Line; G W Hunninghake
Journal:  Am J Med       Date:  1981-03       Impact factor: 4.965

4.  Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Lung volumes, volume-pressure relations, carbon monoxide uptake, and arterial blood gas studied.

Authors:  G L Snider; B R Celli; R H Goldstein; J J O'Brien; E C Lucey
Journal:  Am Rev Respir Dis       Date:  1978-02

5.  Profiles of steady state levels of messenger RNAs coding for type I procollagen, elastin, and fibronectin in hamster lungs undergoing bleomycin-induced interstitial pulmonary fibrosis.

Authors:  R Raghow; S Lurie; J M Seyer; A H Kang
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

6.  Bleomycin selectively elevates mRNA levels for procollagen and fibronectin following acute lung injury.

Authors:  J Kelley; L Chrin; S Shull; D W Rowe; K R Cutroneo
Journal:  Biochem Biophys Res Commun       Date:  1985-09-16       Impact factor: 3.575

7.  Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.

Authors:  R K Assoian; A Komoriya; C A Meyers; D M Miller; M B Sporn
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

8.  Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin.

Authors:  R S Thrall; J R McCormick; R M Jack; R A McReynolds; P A Ward
Journal:  Am J Pathol       Date:  1979-04       Impact factor: 4.307

9.  Bleomycin-induced injury and metaplasia of alveolar type 2 cells. Relationship of cellular responses to drug presence in the lung.

Authors:  I Y Adamson; D H Bowden
Journal:  Am J Pathol       Date:  1979-08       Impact factor: 4.307

10.  Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice.

Authors:  N L Thompson; K C Flanders; J M Smith; L R Ellingsworth; A B Roberts; M B Sporn
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

View more
  139 in total

1.  Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters.

Authors:  Q Wang; Y Wang; D M Hyde; P J Gotwals; V E Koteliansky; S T Ryan; S N Giri
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 2.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 3.  Lung fibrosis.

Authors:  C Fonseca; D Abraham; C M Black
Journal:  Springer Semin Immunopathol       Date:  1999

4.  Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation.

Authors:  Mai-Lan N Huynh; Valerie A Fadok; Peter M Henson
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

5.  Mitogenic activity for fibroblasts induced by silica and titanium dioxide particles in vitro and in vivo.

Authors:  R K Kumar; R O'Grady; W Li; G M Velan
Journal:  Int J Exp Pathol       Date:  1992-10       Impact factor: 1.925

6.  Continuous secretion of monocyte chemotactic factors and fibroblast growth factors by alveolar macrophages following a single exposure to bleomycin in vitro.

Authors:  E M Denholm
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

7.  The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis.

Authors:  C Kuhn; J A McDonald
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

8.  Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.

Authors:  Elizabeth F Redente; Rebecca C Keith; William Janssen; Peter M Henson; Luis A Ortiz; Gregory P Downey; Donna L Bratton; David W H Riches
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

Review 9.  Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease.

Authors:  Tanjina Akter; Richard M Silver; Galina S Bogatkevich
Journal:  Curr Rheumatol Rep       Date:  2014-04       Impact factor: 4.592

10.  Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats.

Authors:  G Westergren-Thorsson; J Hernnäs; B Särnstrand; A Oldberg; D Heinegård; A Malmström
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.